1. Home
  2. PTLE vs TIL Comparison

PTLE vs TIL Comparison

Compare PTLE & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PTLE

PTL LTD Ordinary Shares

N/A

Current Price

$7.36

Market Cap

44.0M

Sector

Energy

ML Signal

N/A

Logo Instil Bio Inc.

TIL

Instil Bio Inc.

HOLD

Current Price

$5.99

Market Cap

52.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTLE
TIL
Founded
2013
2018
Country
Singapore
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.0M
52.2M
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
PTLE
TIL
Price
$7.36
$5.99
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 22.6K
17.5K
Earning Date
11-15-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 6.06
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.09
$5.67
52 Week High
$16.17
$21.64

Technical Indicators

Market Signals
Indicator
PTLE
TIL
Relative Strength Index (RSI) 53.64 23.62
Support Level $6.61 $5.67
Resistance Level $7.86 $7.95
Average True Range (ATR) 0.52 0.27
MACD 0.08 -0.10
Stochastic Oscillator 80.88 5.37

Price Performance

Historical Comparison
PTLE
TIL

About PTLE PTL LTD Ordinary Shares

PTL Ltd is a holding company. Through its subsidiaries, it is an established bunkering facilitator providing marine fuel logistics services for vessel refuelling, serving the Asia Pacific market. The company's services mainly involve facilitating with its suppliers to supply fuel for the use by the customers' vessels at various ports along their voyages in the Asia Pacific region; arranging vessel refuelling activities at competitive pricing to the customers; offering trade credit to the customers for vessel refuelling; handling unforeseeable circumstances faced by the customers and providing contingency solutions to the customers on time; and handling disputes, mainly concerning quality and quantity issues on marine fuel. The company derives its maximum revenue from Hong Kong.

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Share on Social Networks: